The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3)-Reference-Cited by-同舟云学术

The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3)

Published:2005 Issue:3 Volume:11 Page:136-141
ISSN:1075-2617
Container-title:Journal of Peptide Science
language:en
Short-container-title:J. Peptide Sci.

Author:

Boyle Robert G.,Humphries John,Mitchell Tim,Showell Graham A.,Apaya Robert,Iijima Hiroaki,Shimada Hiroshi,Arai Tomonori,Ueno Hiroaki,Usui Yoshihiro,Sakaki Toshiro,Wada Etsuko,Wada Keiji

Publisher

Wiley

Subject

Organic Chemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry,Structural Biology

Reference15 articles.

1. Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy

2. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells.

3. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity

4. Bombesin-like Peptides and Mast Cell Responses

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors;Journal of Pharmacology and Experimental Therapeutics;2019-04-10

2. Constitutively active BRS3 is a genuinely orphan GPCR in placental mammals;PLOS Biology;2019-03-06

3. Pharmacological Effects on Gastric Function;Drug Discovery and Evaluation: Pharmacological Assays;2016

4. Bombesin receptor subtype 3 as a potential target for obesity and diabetes;Expert Opinion on Therapeutic Targets;2015-06-12

5. Pharmacological Effects on Gastric Function;Drug Discovery and Evaluation: Pharmacological Assays;2014